We are live on !
Find out more
DL
Delta Lloyd Portfolio holdings
AUM
$3.56B
Turnover
18.14%
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+18.98%
3 Year Est. Return
+37.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.56B
AUM Growth
+$234M
(+7%)
Cap. Flow
+$114M
Cap. Flow % of AUM
Cap. Flow %
3.19%
Top 10 Holdings %
Top 10 Hldgs %
19.7%
Holding
474
New
48
Increased
200
Reduced
70
Closed
38
Avg Time Held
2.8
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$22.9M |
| 2 |
Starbucks
SBUX
|
+$16.9M |
| 3 |
Cisco
CSCO
|
+$16.8M |
| 4 |
Zimmer Biomet
ZBH
|
+$15.5M |
| 5 |
3M
MMM
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$37M |
| 2 |
Enbridge
ENB
|
+$14.4M |
| 3 |
Apple
AAPL
|
+$11.9M |
| 4 |
Occidental Petroleum
OXY
|
+$10.2M |
| 5 |
Goldman Sachs
GS
|
+$9.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.17% |
| 2 | Technology | 14.83% |
| 3 | Financials | 14.04% |
| 4 | Real Estate | 12.22% |
| 5 | Communication Services | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Axalta
AXTA
$7.31B
| $2.56M | 0.07% |
80,023
+7,984
| +11% | +$255K |
2015 Q2
8 quarters
|
|
252
Hewlett Packard
HPE
$75.3B
| $2.55M | 0.07% |
198,449
-81,209
| -29% | -$1.13M |
2015 Q4
6 quarters
|
|
253
Avery Dennison
AVY
$13.8B
| $2.54M | 0.07% |
28,784
-899
| -3% | -$75.3K |
2014 Q4
10 quarters
|
|
254
Regions Financial
RF
$24.3B
| $2.54M | 0.07% |
173,331
+35,373
| +26% | +$498K |
2013 Q2
16 quarters
|
|
255
Ameriprise Financial
AMP
$43.5B
| $2.54M | 0.07% |
19,916
+1,887
| +10% | +$240K |
2013 Q2
16 quarters
|
|
256
Citizens Financial Group
CFG
$27.4B
| $2.52M | 0.07% |
70,673
+13,579
| +24% | +$481K |
2015 Q2
8 quarters
|
|
257
Omnicom Group
OMC
$22.7B
| $2.51M | 0.07% |
30,251
| – | – |
2013 Q2
16 quarters
|
|
258
Progressive
PGR
$132B
| $2.48M | 0.07% |
56,255
+4,436
| +9% | +$184K |
2013 Q2
16 quarters
|
|
259
Corning
GLW
$107B
| $2.47M | 0.07% |
82,287
-1,752
| -2% | -$50.3K |
2013 Q2
16 quarters
|
|
260
Labcorp
LH
$26.7B
| $2.42M | 0.07% |
18,274
+3,927
| +27% | +$481K |
2013 Q3
15 quarters
|
|
261
Ulta Beauty
ULTA
$26.7B
| $2.39M | 0.07% |
8,319
| – | – |
2014 Q3
11 quarters
|
|
|
XLNX
262
DELISTED
Xilinx Inc
XLNX
| $2.38M | 0.07% |
36,933
| – | – |
2017 Q1
1 quarter
|
|
263
Quest Diagnostics
DGX
$26.7B
| $2.36M | 0.07% |
21,271
+4,153
| +24% | +$439K |
2013 Q2
16 quarters
|
|
264
Best Buy
BBY
$20.9B
| $2.36M | 0.07% |
41,149
| – | – |
2013 Q3
15 quarters
|
|
265
Ormat Technologies
ORA
$5.36B
| $2.35M | 0.07% |
+40,000
| New | +$2.35M |
2017 Q2
0 quarters
|
|
|
VER
266
DELISTED
VEREIT, Inc.
VER
| $2.34M | 0.07% |
57,508
+5,237
| +10% | +$216K |
2014 Q1
13 quarters
|
|
267
Sun Life Financial
SLF
$44B
| $2.26M | 0.06% |
63,156
+13,739
| +28% | +$474K |
2013 Q2
16 quarters
|
|
268
CBRE Group
CBRE
$35.5B
| $2.25M | 0.06% |
61,760
+14,103
| +30% | +$490K |
2013 Q4
14 quarters
|
|
269
Kimco Realty
KIM
$15.8B
| $2.23M | 0.06% |
121,690
-60,302
| -33% | -$1.18M |
2013 Q3
15 quarters
|
|
270
Incyte
INCY
$23.5B
| $2.21M | 0.06% |
17,568
| – | – |
2014 Q4
10 quarters
|
|
271
Idexx Laboratories
IDXX
$44.1B
| $2.19M | 0.06% |
13,560
+2,618
| +24% | +$425K |
2016 Q2
4 quarters
|
|
272
Gaming and Leisure Properties
GLPI
$11.5B
| $2.18M | 0.06% |
57,909
+3,072
| +6% | +$110K |
2017 Q1
1 quarter
|
|
273
T. Rowe Price
TROW
$22.2B
| $2.17M | 0.06% |
29,268
| – | – |
2013 Q2
16 quarters
|
|
274
Cencora
COR
$63.2B
| $2.16M | 0.06% |
22,793
+2,707
| +13% | +$241K |
2013 Q2
16 quarters
|
|
275
Centene
CNC
$34.7B
| $2.15M | 0.06% |
53,888
+12,536
| +30% | +$473K |
2015 Q2
8 quarters
|
|
Similar funds
CAM
TCM
HCM
AL
Delta Lloyd's Q2 2017 Portfolio in Review
As of Q2 2017, Delta Lloyd held 474 positions worth $3.56B, up 7% from $3.33B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Delta Lloyd deployed $114M of net new capital in Q2 2017, opening 48 new positions and adding to 200 existing holdings. Its largest new stake was Zimmer Biomet: 130,529 shares worth $16.3M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $37M trimmed.
- Delta Lloyd's largest Q2 2017 buy was Zimmer Biomet: 130,529 shares worth $16.3M.
- Delta Lloyd added most to Citigroup in Q2 2017, an estimated $22.9M increase.
- Delta Lloyd's biggest Q2 2017 reduction was JPMorgan Chase, cutting an estimated $37M.
- Delta Lloyd fully exited Enbridge in Q2 2017, selling an estimated $14.4M.
- Delta Lloyd's ten largest holdings make up 20% of its $3.56B portfolio in Q2 2017.
- Delta Lloyd opened 48 new positions and closed 38 in Q2 2017.
- Delta Lloyd's portfolio value rose 7% quarter-over-quarter to $3.56B.
Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.